The University of Chicago Header Logo

Connection

S. Murray Sherman to Tumor Burden

This is a "connection" page, showing publications S. Murray Sherman has written about Tumor Burden.
Connection Strength

0.040
  1. Impact of baseline tumor burden on overall survival in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial. Cancer. 2022 06 15; 128(12):2281-2287.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.